# OnCo record paper-gisslinger-lancet-haematol (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-gisslinger-lancet-haematol/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-gisslinger-lancet-haematol" ;
  schema:name "Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study"@en ;
  schema:description "Paper cited by one trial page, indexed on Europe PMC as PubMed record 32014125 and published in The Lancet Haematology; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-gisslinger-lancet-haematol/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s2352-3026(19)30236-4>, <https://pubmed.ncbi.nlm.nih.gov/32014125/>, <https://europepmc.org/article/MED/32014125> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s2352-3026(19)30236-4> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Gisslinger H, Klade C, Georgiev P, et al." ;
  onco:trials <https://onco.cc/trials/proud-pv/> ;
  onco:journals <https://onco.cc/journals/lancet-haematology/> .